uniQure (QURE) Ests and PT Cut After Dropping Glybera - Jefferies
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq drop on tech selloff as concerns about hawkish Fed, AI spending mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Chardan Capital Says uniQure (QURE) on Pullback, Slight Delay to AMT-060 is Immaterial
December 1, 2015 10:04 AM ESTChardan Capital affirms its Buy rating and $40 price target on uniQure N.V. (Nasdaq: QURE) following the company's Q3 report and update issued on Monday.
Analyst Gbola Amusa says investors should buy on post-Q3 weakness. The analyst noted the following key points from the company's quarterly conference call:
AMT-060 (hemophilia B): In early January 2016 (previously due by end-2015), uniQure will release preliminary, top-line data for 2 patients who have completed at least 12 weeks of treatment, with full results from the first cohort of 5 patients at a scientific conference... MoreuniQure BV (QURE) Sell-Off 'Unfounded' - Oppenheimer
December 1, 2015 7:11 AM ESTOppenheimer Christopher Marai views yesterday's nearly 17% sell-off in uniQure BV (NASDAQ: QURE) unfounded. As such, the firm reiterated an Outperform rating and price target of $50.
uniQure reported 3Q15, ending the quarter with $215M in cash.
Marai commented, "Importantly, QURE clarified the... More
Janney Capital Starts uniQure BV (QURE) at Buy
November 30, 2015 5:10 PM ESTJanney Capital initiated coverage on uniQure BV (NASDAQ: QURE) with a Buy rating and a price target of $40.00.
For an analyst ratings summary and ratings history on uniQure BV click here. For more ratings news on uniQure BV click here.
Shares of uniQure BV closed at $22.50 yesterday.
... MoreuniQure BV (QURE) Ph1/2 MPS3b Has Strong Reception at ICSS - Cowen
November 30, 2015 7:44 AM ESTCowen analyst Ritu Baral reiterated an Outperform rating on uniQure BV (NASDAQ: QURE) Ph1/2 12 mo. MPS3b AMT-110 data was presented again at ICSS Friday and was very well received by MPS3 KOLs.
Baral commented, "The trial PI noted 18 more mos. of... More
uniQure (QURE) Misses Q3 EPS by 3c
November 30, 2015 7:34 AM ESTuniQure (NASDAQ: QURE) reported Q3 EPS of (EUR0.67), EUR0.03 worse than the analyst estimate of (EUR0.64). Revenue for the quarter came in at EUR3.15 million versus the consensus estimate of EUR2.8 million.
For earnings history and earnings-related data on uniQure (QURE) click here.
... More